Assessment of antibody levels to SARS-CoV-2 in patients with idiopathic inflammatory myopathies receiving treatment with intravenous immunoglobulin

Antibodies to Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) have been reported in pooled healthy donor plasma and intravenous immunoglobulin products (IVIG). It is not known whether administration of IVIG increases circulating anti-SARS-CoV-2 antibodies (COVID ab) in IVIG recipients....

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Sangmee Sharon, Faure-Kumar, Emmanuelle, Ferbas, Kathie, Wang, Jennifer, Shahbazian, Ani, Truong, Linh, Yang, Howard, McMahon, Maureen, FitzGerald, John D., Charles-Schoeman, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348966/
https://www.ncbi.nlm.nih.gov/pubmed/37368037
http://dx.doi.org/10.1007/s00296-023-05350-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348966/
https://www.ncbi.nlm.nih.gov/pubmed/37368037
http://dx.doi.org/10.1007/s00296-023-05350-1

Ejemplares similares